Skip to main content
. 2018 Jan 9;11:1756283X17745776. doi: 10.1177/1756283X17745776

Figure 5.

Figure 5.

Metabolic disposition pathways of vonoprazan.

The major route of metabolic disposition of vonoprazan was reported via CYP3A4, which converts vonoprazan to compounds M-I and M-III (thick arrows). Although CYP2D6, CYP2C9 and CYP2C19, and sulfotransferase2A1 (SULT2A1) also participate in metabolic disposition, their roles are relatively minor. M-I-G* and M-II-G* were inferred glucuronic-acid-conjugated (G) products from M-I, and M-II, respectively. Data are taken from the Pharmaceuticals and Medical Devices Agency of Japan32 with some modifications.